- conflicts or gaps
- [[{"field": {"value": "funding.total_raised_usd", "source_urls": ["https://www.cbinsights.com/company/cambridge-bio-augmentation-systems", "https://uk.linkedin.com/company/bios-health-inc"]}, "issue": {"value": "CB Insights reports ~$26.95M total raised; LinkedIn reports $46.8M total funding. No primary-source audited total found.", "source_urls": ["https://www.cbinsights.com/company/cambridge-bio-augmentation-systems", "https://uk.linkedin.com/company/bios-health-inc"]}}, {"field": {"value": "employees.snapshots", "source_urls": ["https://www.ycombinator.com/companies/bios-health", "https://uk.linkedin.com/company/bios-health-inc"]}, "issue": {"value": "YC lists team_size 45; LinkedIn lists 21 employees (11-50 range). No dated primary headcount disclosure found.", "source_urls": ["https://www.ycombinator.com/companies/bios-health", "https://uk.linkedin.com/company/bios-health-inc"]}}, {"field": {"value": "funding.rounds[3].stage", "source_urls": ["https://www.bios.health/bios-fundraise-press-release-6-23", "https://www.cambridgeindependent.co.uk/business/bios-health-neural-model-adds-backers-of-extraordinary-qual-9319473/", "https://www.cbinsights.com/company/cambridge-bio-augmentation-systems/financials"]}, "issue": {"value": "Company calls Jun 2023 financing a 'venture round' (not Series A/B/C); spokesperson said it could be 'Series A+ or early Series B'; CB Insights labels it Series A for $20M; company press release did not disclose amount.", "source_urls": ["https://www.bios.health/bios-fundraise-press-release-6-23", "https://www.cambridgeindependent.co.uk/business/bios-health-neural-model-adds-backers-of-extraordinary-qual-9319473/", "https://www.cbinsights.com/company/cambridge-bio-augmentation-systems/financials"]}}, {"field": {"value": "founders[1].role", "source_urls": ["https://www.bios.health/about-us", "https://find-and-update.company-information.service.gov.uk/company/09575301/filing-history"]}, "issue": {"value": "Oliver Armitage listed as CSO & Founder on company website but terminated as UK director on 2024-08-05 per Companies House filing TM01.", "source_urls": ["https://www.bios.health/about-us", "https://find-and-update.company-information.service.gov.uk/company/09575301/filing-history"]}}, {"field": {"value": "funding.rounds[4].amount_usd", "source_urls": ["https://pub-bakersfield.escribemeetings.com/filestream.ashx?DocumentId=12465", "https://www.yahoo.com/news/articles/neurotech-spinoff-kordata-aims-bring-035900011.html"]}, "issue": {"value": "Official Bakersfield City Council minutes (May 2025) approve up to $250,000 economic subsidy; secondary reporting (Yahoo/Kordata article) references $500,000 total city awards to BIOS.", "source_urls": ["https://pub-bakersfield.escribemeetings.com/filestream.ashx?DocumentId=12465", "https://www.yahoo.com/news/articles/neurotech-spinoff-kordata-aims-bring-035900011.html"]}}, {"field": {"value": "funding.rounds (YC standard deal)", "source_urls": ["https://www.ycombinator.com/companies/bios-health"]}, "issue": {"value": "Y Combinator W17 participation confirmed but standard YC investment amount/terms not found in sources checked.", "source_urls": ["https://www.ycombinator.com/companies/bios-health", "https://www.bios.health/bios-fundraise-press-release-6-23"]}}, {"field": {"value": "products (hardware pivot)", "source_urls": ["https://sifted.eu/articles/ai-startup-bios-health-raise-news", "https://www.ycombinator.com/companies/bios-health"]}, "issue": {"value": "Company pivoted from prosthetic neural-interface hardware (CBAS era) toward software/platform and integration with third-party implant manufacturers; current commercial product maturity unclear from primary sources.", "source_urls": ["https://www.ycombinator.com/companies/bios-health", "https://sifted.eu/articles/ai-startup-bios-health-raise-news"]}}, {"field": {"value": "identity.other_locations", "source_urls": ["https://uk.linkedin.com/company/bios-health-inc", "https://www.bios.health/about-us"]}, "issue": {"value": "LinkedIn incorrectly lists Montreal under United States offices; company about page correctly places Montreal in Canada.", "source_urls": ["https://uk.linkedin.com/company/bios-health-inc", "https://www.bios.health/about-us"]}}]]
- source urls
- ["https://find-and-update.company-information.service.gov.uk/company/09575301", "https://find-and-update.company-information.service.gov.uk/company/09575301/filing-history", "https://pub-bakersfield.escribemeetings.com/filestream.ashx?DocumentId=12465", "https://sifted.eu/articles/ai-startup-bios-health-raise-news", "https://techcrunch.com/2018/12/04/bios-health/", "https://uk.linkedin.com/company/bios-health-inc", "https://www.bakersfield.com/news/city-council-approves-grant-for-neurotech-startup/article_e6e52942-5f8a-4e73-a793-b616b00b6a38.html", "https://www.bios.health", "https://www.bios.health/about-us", "https://www.bios.health/bios-fundraise-press-release-6-23", "https://www.bios.health/bios-moves-into-clinics-via-21m-neural-research-project", "https://www.bios.health/neuromod-prize-phase-1-win", "https://www.bios.health/news-story-new-neurocardiology-funding", "https://www.bios.health/news-story-nvidia-gpus", "https://www.cambridgeindependent.co.uk/business/bios-health-neural-model-adds-backers-of-extraordinary-qual-9319473/", "https://www.cbinsights.com/company/cambridge-bio-augmentation-systems", "https://www.cbinsights.com/company/cambridge-bio-augmentation-systems/financials", "https://www.yahoo.com/news/articles/neurotech-spinoff-kordata-aims-bring-035900011.html", "https://www.ycombinator.com/companies/bios-health"]